New President Named at MED Institute

MED Institute has appointed Steve Charlebois as president to succeed Neal Fearnot, who is retiring after nearly 40 years. Under Fearnot’s leadership, MED Institute has grown into a trusted partner for medical innovators, advancing product development worldwide.

Charlebois previously served as vice president at the Institute and has 25 years of experience in the medical product development industry. His expertise and leadership will be invaluable as the organization continues to innovate and grow, executives said.

David Gross is succeeding Charlebois as vice president. Gross has played a crucial role in directing MRI Safety Evaluations and Computational Modeling and Simulation (CM&S) groups, contributing to the company’s reputation for technical excellence and cutting-edge technologies.

Scott Williams has been named vice president, Regulatory/Clinical Services. With more than 20 years of experience in clinical studies and regulatory affairs, Williams has established a respected reputation with regulators and has guided approval/clearance of several currently-marketed products with significant impact on patient care.

“This transition marks an exciting new chapter for MED Institute,” Charlebois said. “We remain dedicated to advancing medical technology and delivering the highest level of support to our clients. I look forward to building upon the strong foundation that Neal has established.”

MED Institute accelerates product development and is focused on bringing new medical products to the market that are safe and effective for patients. From concept to commercialization, the Institute’s team is knowledgeable and experienced in guiding products through the complex steps required for market approval.